WACKER and Biosyntia to develop large-scale production process for sustainable biotin
Danish biotech company Biosyntia and the Munich-based WACKER Group will form a partnership to develop a large-scale production process for fermentation-based biotin. The aim of the collaboration is to make fermentation-based biotin available for the market as a sustainable, non-chemical, European-sourced alternative. The biotin currently available on the market is synthetically produced from non-renewable […]
